Journal of Agricultural and Food Chemistry · 2018 · 16 citations · 23 references
PharmacyOncologyPharmacologyDrug DeliveryMolecular OncologyTargeted Drug DeliveryCancer BiotechnologyCancer NanomedicineNanocarriers For TherapeuticsNanomedicineTargeted Cancer TherapyTargeted TherapyCancer NanotherapyEgfr InhibitionEpidermal Growth Factor Receptor EndocytosisEpidermal Growth Factor Receptor Targeting LigandsEscherichia ColiPlant-based OilsTherapeutic Targeting Of Fusion ProteinsTumor-targeted Drug Delivery
Lung cancer is the most widespread disease and is frequently associated with a high level of epidermal growth factor receptor (EGFR). This study was thus conducted to provide a proof-of-concept approach for targeted therapy of lung cancer by development of nanoscale oil bodies (NOBs). This was carried out by fusion of anti-EGFR affibody (ZEGFR2) with oleosin (Ole), a structure protein of plant seed oils. The fusion protein (Ole-ZEGFR2) was produced in Escherichia coli. NOBs were spontaneously assembled from plant oil, phospholipids, and Ole-ZEGFR2. Consequently, Ole-ZEGFR2-based NOBs were selectively internalized by EGFR-positive lung cancer cells with an efficiency exceeding 90%. Furthermore, the hydrophobic anticancer drug, camptothecin (CPT), was encapsulated into Ole-ZEGFR2-based NOBs. The administration of the CPT formulation based on NOBs resulted in a strong antitumor activity both in vitro and in vivo.
23
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2016 · 16.2K citations · Full text
Surface structure and properties of plant seed oil bodies
The Journal of Cell Biology · 1992 · 504 citations · Full text
Antitumor Activity of Peptide Amphiphile Nanofiber-Encapsulated Camptothecin
Stephen Soukasene, Daniel J. Toft, Tyson J. Moyer et al. · ACS Nano · 2011 · 248 citations